Introduction {#sec0005}
============

The newly emerging coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has a significant mortality rate and has spread across nearly the entire world. Although lots of research has been conducted, reports on the pathology of living lung tissue are scarce, due to the limited number of biopsies performed.

In this study, the pathological characteristics of a live patient suffering from severe infection with SARS-CoV-2 were investigated. This study was performed in accordance with the regulations issued by the National Health Commission of China. The study findings will facilitate understanding of the histopathology of COVID-19 and its treatment, and improve clinical strategies against the disease.

Case report {#sec0010}
===========

On February 3, 2020, a 55-year-old man was admitted to a fever clinic in Yantai, China, with a 3-day history of high fever, dry cough, fatigue, and shortness of breath. He disclosed that his son had returned to their hometown from epidemic-hit Wuhan on January 21. The patient had taken oral anti-fever medicine, but the fever could not be controlled. His chest computed tomography (CT) showed bilateral multifocal ground glass opacities with consolidation, which suggested viral pneumonia as a differential diagnosis ([Figure 1](#fig0005){ref-type="fig"} A, B). He was immediately admitted to the isolation ward and received supplemental oxygen through a face mask. On February 4, 2019-nCoV pneumonia nucleic acid testing returned a positive result. Based on real-time reverse transcriptase PCR (rRT-PCR) for SARS-CoV-2, chest CT, and clinical and epidemiological information, the patient received a diagnosis of COVID-19.Figure 1Unenhanced computed tomography images of the patient diagnosed with COVID-19 pneumonia: (A) (February 3, 2020, illness day 3) multiple subpleural ground glass opacities (GGO) in both lungs. (B) (February 5, 2020, illness day 5) progressive enlargement and patchy consolidation of former GGOs in the bilateral lungs, with crazy-paving pattern (GGO with superimposed interlobular and intralobular septal thickening). (C) (March 7, 2020, illness day 36) posteroanterior chest radiographs, showing 'white lung'.Figure 1

The patient had no notable underlying disease before the onset of COVID-19. Physical examination revealed a body temperature of 36.8 °C, blood pressure of 134/91 mmHg, pulse of 70 beats per minute, respiratory rate of 23 breaths per minute, and arterial oxygen saturation (SpO~2~) of 68% while the patient was breathing supplemental oxygen via a mask at 5 l/min. Breathing sounds were initially normal. The laboratory results reflected lymphopenia (6.5%).

A repeat chest CT showed significant progression of the bilateral ground glass opacities in a diffuse distribution, which progressed to 'white lung', as shown in [Figure 1](#fig0005){ref-type="fig"}C. The laboratory results reflected lymphopenia (6.5%) and decreased cellular immunity (CD3+CD4+, 145/μl). A rapid screening test for inﬂuenza A and B was negative. Some of the other laboratory abnormalities identified during routine testing in this case are reported in [Table 1](#tbl0005){ref-type="table"} , including among others elevated SpO~2~, lactate, white blood cell count, absolute lymphocyte count, platelet count, oxygen, and carbon dioxide. Despite every effort, the patient's illness continued to worsen, so a percutaneous lung biopsy under ultrasound guidance was performed at 11 a.m. on day 41 of illness. Unfortunately, the patient died during the night on the same day.Table 1Clinical and laboratory data.Table 1Laboratory examinationReference Range13141617192325262728293132333435363738394041White-cell count (per ul)3500--950086101429016820183001089070309310840067500-5020519033604580-2630-580065605250-15630Meutrophil (%)40--759295.89895.79395.387.180.778.6-8881.875.573.9-66.4-85.587.192-90.1Absolute lymphocyte count (per ul)1100--320053039022038044021078012601140-370630500880-620-480-290-1060Platelet count (×10^5^ (per ul)1.0--3.0\-\--1.091.211.10.771.170.86-0.710.560.850.890.510.83\--0.860.860.760.94Oxygen (mmHg)83--108743359104597055685864497046646575715146605646Carbon dioxide (mmHg)35--4532.244.639.342.650.35243.739.540.545.852.247.659.946.654.544.440.969.455.351.747.259.8Lactate (mmol/liter)0.5--1.622.62.62.52.51.94.22.11.91.62.20.71.50.9-0.8\-\--22-Procalcitonin (ng/ml)0--0.060.2570.3130.3410.2070.1230.061-0.1290.206\--2.380\-\-\--.0491\-\--0.5050.414C-reactive protein (mg/liter)0--5102.74-986721.6422.188.1631.7449.68\--106.82\-\-\--102.33\-\--104.5991.9Fibrinogen (g/liter)2--46.65\--3.471.87-1.722.692.983.495.026.584.313.15-3.08\-\-\--3.411.39Alanine aminotransferase (U/liter)9--50143.8\--3964-8470.6102.2\--162.7\-\-\-\-\-\-\--21-Aspartate aminotransferase (U/liter)15--4057.8\--3970-6153.971.3\--62\-\-\-\-\-\-\--53.6-Gamma-glutamyl transpeptidase (U/liter)11--49184\--120\--127127201\--407\-\-\--317.65\-\-\-\--

The biopsy specimen was fixed at different times with an interval of 24 h. The first biopsy specimen showed alveolar structure collapse, occlusion, and massive fibrinoid necrosis, and a cellulose exudate could be seen in the residual alveolar space. Alveolar epithelial hyperplasia was evident ([Figure 2](#fig0010){ref-type="fig"} A). The later lung biopsy specimen showed extensive lung tissue necrosis, most of the alveolar septa were destroyed, the fibrous scaffolds had disappeared, and only a few alveolar structures were preserved; this was accompanied by significant fibrinous exudate and hemorrhage. Necrotic and exfoliated alveolar epithelial cells and chronic inflammatory cells could be seen in the exudates, and the latter was mainly composed of mononuclear cells and lymphocytes. Mucus could be seen in some areas. The walls of the small vessels in the interstitium of the lung showed fibrinoid necrosis ([Figure 2](#fig0010){ref-type="fig"}B, C). Large amounts of virus were observed by electron microscopy, and the virions were 97--102 nm in diameter ([Figure 2](#fig0010){ref-type="fig"}D). The later part had high levels of necrosis.Figure 2(A) (B) (C) Pathological manifestations in the lung tissue biopsy of the patient with severe pneumonia caused by SARS-CoV-2; hematoxylin and eosin staining. (D) Transmission electron micrograph (bar 500 nm and 200 nm).Figure 2

Meanwhile, several important inflammatory markers were also observed. Granulocytes showed strong positive expression of myeloperoxidase (MPO) ([Figure 3](#fig0015){ref-type="fig"} A), IgG was strongly positively expressed ([Figure 3](#fig0015){ref-type="fig"}B), and IgD and interleukin (IL)-10 were weakly positively expressed ([Figure 3](#fig0015){ref-type="fig"}C, D). IL-6 and tumor necrosis factor alpha (TNF-α) were strongly positively expressed ([Figure 3](#fig0015){ref-type="fig"}E, F); angiotensin-converting enzyme 2 (ACE2) was positively expressed in alveolar epithelial cells ([Figure 3](#fig0015){ref-type="fig"}G).Figure 3Expression of markers in the lung biopsy: (A) myeloperoxidase (MPO); (B) immunoglobulin G (IgG); (C) immunoglobulin D (IgD); (D) interleukin 10 (IL-10); (E) interleukin 6 (IL-6); (F) tumor necrosis factor alpha (TNF-α); (G) angiotensin-converting enzyme 2 (ACE2).Figure 3

Discussion {#sec0015}
==========

So far, few autopsy studies on patients with severe COVID-19 have been reported. In this study, the pathological characteristics of a patient with severe COVID-19 were investigated. The study findings will facilitate understanding of the pathogenesis of COVID-19 and improve clinical strategies against the disease.

Most elderly COVID-19 patients with comorbidities such as hypertension, diabetes, and coronary heart disease are critically ill or die. However, a significant proportion of middle-aged adults with no underlying diseases have also become severely infected, like the patient reported here. In this case, biopsy samples from the lung were taken at the bedside under ultrasound guidance. The later lung biopsy showed extensive lung tissue necrosis; type II alveolar epithelial hyperplasia could be seen and no virus inclusions and multinucleated cells were found. The residual bronchial epithelial cells were found in the local tissue. Due to extensive lung tissue necrosis, there was no alveolar hyaline membrane or other structures.

The pathological features of COVID-19 resemble those seen in severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) ([@bib0010], [@bib0020], [@bib0015]). However, the former showed relatively mild damage. The morphological changes in the patient's lungs conformed to late manifestations of a severe case. The findings indicate that the virus may continue to destroy the lung tissue after the virus has left the body. To some extent, self-degradation and destruction of the tissues cannot be ruled out. Nevertheless, the autopsy results cannot fully represent the patient's disease status. Virus was also observed in the lung tissue by transmission electron microscopy.

ACE2 is a cell surface protein highly expressed in the lung, kidney, and heart ([@bib0025]). SARS-CoV-2 targets the lung and other organs and causes multiorgan damage by binding to the ACE2 receptor ([@bib0030]). Inflammatory cytokines and chemokines, including IL-6 and TNF-α, have been found to be significantly elevated in COVID-19 patients. In the case presented here, expression of ACE2, IL-6, and TNF-α was observed. MPO is a peroxidase mainly produced by granulocytes (neutrophils and tissue monocytes) ([@bib0005]). The expression of MPO was strongly positive, but neutrophils were scarce in the lung tissue of the patient at that time, suggesting that there may be a large amount of granulocyte infiltration into the lung tissue before and during the middle stage of the disease, resulting in a large amount of MPO production and a local superoxide reaction. In the later stage, the granulocytes may break apart, resulting in MPO accumulation in the lung tissue, which could lead to severe tissue damage (closely related to the oxidative stress response).

According to the pathological findings in the patient with severe COVID-19 presented here, this study not only helped to identify a cause of death, but also facilitates understanding of the pathogenesis of the disease, which might help the multidisciplinary team to formulate a timely therapeutic strategy and reduce mortality for similar severe patient cases.
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